Laxxon Medical Corp. ("Laxxon Medical" or the "Company"), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs ...
Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical ...
October 19 proved to be an emotional rollercoaster for Taiwan’s biotechnology investors. Within hours, three major material ...
Siren Biotechnology, a clinical-stage biotechnology company pioneering Universal AAV Immuno-Gene Therapy for cancer, today announced the appointment of Peter Bross, MD, former Chief of the Oncology ...
Germany is the European Union’s (EU) largest pharmaceutical market by revenue and has the highest medical biotechnology ...
Inhibikase Therapeutics Appoints Scott Wasserman to Board of Directors as Phase 3 PAH Trial Advances
Inhibikase Therapeutics, Inc. (Nasdaq: IKT), a Wilmington, Delaware-based clinical-stage pharmaceutical company, has appointed Scott M. Wasserman, MD, to its Board... Read More ...
Spread the loveImagine a world where the agonizing wait for a new life-saving drug is drastically cut short, where illnesses ...
Insilico Medicine founder and CEO Dr. Alex Zhavoronkov details how his company is developing medicine targeting age and ...
She runs the Medical Research and Education Institute at Moscow State University ...
Since 1987, October in the UK has been celebrated as Black History Month, a time to instill pride and reflect on those who ...
PRNewswire/ -- eGlint, Inc., a biotechnology company developing next-generation extremely rapid proteomics technologies, ...
Sensorion (FR001401A9Z0 – ALSEN), a clinical-stage biotechnology company developing treatments for hearing loss, has appointed Peter Weber, MD, MBA, as... Read More ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results